C Bart Rountree

Author PubWeight™ 11.40^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.	Hepatology	2010	1.63
2	c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.	Hepatology	2011	1.61
3	Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.	Hepatology	2010	1.60
4	CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.	Hepatology	2009	1.40
5	Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.	Hepatology	2007	1.30
6	Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.	Gastroenterology	2010	1.25
7	Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.	BMC Cancer	2011	1.09
8	Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.	PLoS One	2012	0.94
9	Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.	Hepatology	2012	0.93